Magellan Diagnostics LeadCare and LeadCare II test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only. The Test Kit is for the quantitative measurement of lead in fresh whole blood. This product is for professional use only. Sensors and Treatment Reagent of the Test Kit are specific for lead only. Contents of this LeadCare Blood Lead Test Kit must only be used with a LeadCare Analyzer and Blood Lead Testing System.
Publicado el 14 de junio de 2017 · Inicio del retiro: 23 de mayo de 2017
Resumen
FDA registra el retiro Z-2225-2017 de dispositivos médicos de Clase I, publicado el 14 de junio de 2017 e iniciado el 23 de mayo de 2017. Empresa responsable: Magellan Diagnostics, Inc.; Estado: Finalizado; Cantidad reportada: 171,979 kits (total)= 153,447 (US)and 18532 (OUS); Lote: All lot codes. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Underestimates the lead concentration of venous blood samples when the sample is analyzed with the LeadCare systems
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Magellan Diagnostics, Inc.
- Distribuidor
- Worldwide Distribution - US (Nationwide) Foreign: AUSTRALIA AUSTRIA BOLIVIA CANADA CHILE CHINA COLOMBIA DOMINICAN REPUB ENGLAND GERMANY INDIA UK ISRAEL ITALY JAPAN KOREA MALI MYANMAR SPAIN NEPAL NETHERLANDS NEW ZEALAND P.R. CHINA PANAMA US PERU PHILLIPINES POLAND PORTUGAL REP OF KOSOVO SOUTH AFRICA SRI LANKA USA SWEDEN SWITZERLAND TRINIDAD UNITED ARAB EMI VIETNAM
- Lote
- All lot codes
- Clasificación de riesgo
- Class I
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDALeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.21 de octubre de 2026
- FDALeadCare Ultra Blood Lead Test Kit Catalog Number 70-80987 de julio de 2021
- FDALeadCare Plus Blood Lead Analyzer Part Number: 82-0001 Intended for the quantitative measurement of lead in a11 de abril de 2018
- FDAUrea Base Agar, Acumedia PN 7226 Urea Agar Base is used with agar for the differentiation of microorganisms on14 de junio de 2017
- FDASesamoid Plasty, Stereotaxic Instrument The Sesamoid Plasty workstation is used to run the tracking software14 de junio de 2017
- FDAMagellan Diagnostics LeadCare Ultra Blood Lead Test Kits Part Number: 80-001024 de mayo de 2017
Preguntas sobre este retiro
¿Magellan Diagnostics LeadCare and LeadCare II test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only. The Test Kit is for the quantitative measurement of lead in fresh whole blood. This product is for professional use only. Sensors and Treatment Reagent of the Test Kit are specific for lead only. Contents of this LeadCare Blood Lead Test Kit must only be used with a LeadCare Analyzer and Blood Lead Testing System. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2225-2017 el 14 de junio de 2017. Peligro reportado: Underestimates the lead concentration of venous blood samples when the sample is analyzed with the LeadCare systems
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter